Archive: 27/03/2019

Fulvestrant plus anastrozole extends lives of women with advanced HR+ breast cancer

Women with metastatic hormone receptor-positive breast cancer live longer when they receive a combination of two anti-estrogen drugs, fulvestrant and anastrozole, compared with treatment with anastrozole alone, according ...

Mar 27, 2019

Fewer reproductive years in women linked to an increased risk of dementia

Women who start their period later, go through menopause earlier or have a hysterectomy may have a greater risk of developing dementia, according to a new study published in the March 27, 2019, online issue of Neurology, ...

Mar 27, 2019

0

41

Heart failure hospitalizations spike when flu season peaks

(HealthDay)—Weakened hearts grow weaker and fail when influenza rages throughout the land, a new study reports.

Mar 27, 2019

0

15

Infants born weighing <400 g who survive at risk for severe morbidity

(HealthDay)—One-fifth of infants born with a birth weight (BW) less than 400 g survive to 18 to 26 months' corrected age, but they are at high risk for neurodevelopmental impairment, according to a study published online ...

Mar 27, 2019

0

0

FDA OKs new drug for multiple sclerosis

(HealthDay)—A new pill for relapsing forms of multiple sclerosis (MS) has won approval from the U.S. Food and Drug Administration.

Mar 27, 2019

0

3

Study of female weightlifters crushes stereotype

In the first-ever study of its kind, San Francisco State University and California State University, Fullerton researchers found that elite women weightlifters have the same amount—and in some cases more—of the muscle ...

Mar 27, 2019

0

891

After 4 strokes, rare disease and brain surgery, woman helps others

When Lisa Deck was chosen as a Go Red for Women national spokeswoman in 2014, she was thrilled to have a larger platform to help raise awareness about heart disease and stroke.

Mar 27, 2019

0

5

Taxane + platinum feasible for adjuvant tx in endometrial cancer

(HealthDay)—Taxane plus platinum regimens may be a reasonable alternative to doxorubicin plus cisplatin as postoperative adjuvant chemotherapy for endometrial cancer that carries a high risk for progression, according to ...

Mar 27, 2019

0

1

Adding transition services does not aid heart failure outcomes

(HealthDay)—Additional transitional care services do not improve outcomes for heart failure patients discharged from the hospital, according to a study recently published in the Journal of the American Medical Association.

Mar 27, 2019

0

3

FDA says breast density must be reported to women during mammograms

(HealthDay)—Women with dense breasts who get mammograms must be told of their higher risk for breast cancer under new rules proposed Wednesday by the U.S. Food and Drug Administration.

Mar 27, 2019

0

6

page 2 from 9

«
»